During the past decade, Hospital Nacional Edgardo Rebagliati Martins conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 7 clinical trials were completed, i.e. on average, 140% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Nacional Edgardo Rebagliati Martins" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "University of Minnesota" with 2 trials sponsored, "CTI BioPharma" with 1 trials sponsored, "Cytokinetics" with 1 trials sponsored and "Fresenius Kabi" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Nacional Edgardo Rebagliati Martins" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Cancer International Research Group (CIRG)" with 1 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Nacional Edgardo Rebagliati Martins" are "Breast Cancer" (2 trials), "Acute Peripheral Arterial Occlusion" (1 trials), "Adult T-cell Leukemia-Lymphoma" (1 trials), "Breast Neoplasms" (1 trials) and "Caloric Deficit" (1 trials). Many other conditions were trialed in "Hospital Nacional Edgardo Rebagliati Martins" in a lesser frequency.

Most popular intervention types in "Hospital Nacional Edgardo Rebagliati Martins" are "Drug" (12 trials), "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Capecitabine" (2 trials), "Carboplatin" (2 trials), "Trastuzumab" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Nacional Edgardo Rebagliati Martins" are 17 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Nacional Edgardo Rebagliati Martins". 1 are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Hospital Nacional Edgardo Rebagliati Martins, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Nacional Edgardo Rebagliati Martins, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".